Over the past three months, shares of Baker Hughes Inc. (NASDAQ:BKR) rose by 11.22%. Before having a look at the importance of debt, let's look at how much debt Baker Hughes has.
Gainers
Exela Technologies, Inc. (NASDAQ: XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions.
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Thursday.
The Dow traded up 0.31% to 32,764.50 while the NASDAQ fell 0.49% to 11,324.28. The S&P 500 also fell, dropping, 0.21% to 3,943.00.
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 80 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.24% to 32,740.88 while the NASDAQ fell 0.58% to 11,313.95. The S&P 500 also fell, dropping, 0.30% to 3,939.53.
Shares of Amgen Inc. (NASDAQ:AMGN) fell by 17.83% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Over the past three months, shares of Hershey Inc. (NYSE:HSY) moved higher by 1.22%. Before having a look at the importance of debt, let's look at how much debt Hershey has.
Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) moved lower by 46.87%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Shares of American Electric Power Inc. (NASDAQ:AEP) moved lower by 8.81% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Shares of Cheniere Energy Inc. (AMEX:LNG) decreased by 8.34% in the past three months. Before having a look at the importance of debt, let's look at how much debt Cheniere Energy has.
Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.